Volume 32, Issue 4 pp. e65-e66
DEN Video Article
Free Access

Simultaneous triple side-by-side metal stent deployment for malignant hilar biliary obstruction

Tadahisa Inoue

Corresponding Author

Tadahisa Inoue

Department of Gastroenterology, Aichi Medical University, Aichi, Japan

Corresponding: Tadahisa Inoue, Department of Gastroenterology, Aichi Medical University, 1-1 Yazakokarimata, Nagakute, Aichi 480-1195, Japan. Email: [email protected]

Search for more papers by this author
Kiyoaki Ito

Kiyoaki Ito

Department of Gastroenterology, Aichi Medical University, Aichi, Japan

Search for more papers by this author
Masashi Yoneda

Masashi Yoneda

Department of Gastroenterology, Aichi Medical University, Aichi, Japan

Search for more papers by this author
First published: 19 February 2020
Citations: 3

Abstract

Watch a video of this article

Brief Explanation

Triple deployment of metal stents (MSs) in high-grade malignant hilar biliary obstruction (MHBO) is technically challenging.1-4 Although combined side-by-side (SBS) and stent-in-stent deployment might reduce its difficulty, the insertion of the third MS remains a concern.5 A new MS that has a 5.4-Fr ultra-thin delivery system (Zeo Stent V; Zeon Medical, Tokyo, Japan) was recently developed, and it facilitates simultaneous triple SBS deployment (Fig. 1). Herein, we report an initial case of simultaneous triple SBS deployment using this MS for MHBO.

Details are in the caption following the image
A newly developed metal stent with a 5.4-Fr ultra-thin delivery system (Zeo Stent V; Zeon Medical) that facilitates triple simultaneous insertion into the 4.2-mm working channel of a duodenal scope

A woman in her 80s with cholangiocarcinoma with liver metastasis developed jaundice due to Bismuth type IV MHBO. Pre-drainage of two biliary branches was insufficient. To ensure achievement of successful three-branched drainage and as the patient's common bile duct (CBD) was large, we performed simultaneous triple SBS method. After the insertion of a TJF260V (Olympus Medical Systems Corporation, Tokyo, Japan) and three 0.025-inch guidewires into the left hepatic duct, right anterior sectoral duct, and right posterior sectoral duct across the stricture, the three delivery systems of the Zeo Stent V (all 8 mm in diameter and 60 mm in length) were simultaneously inserted into these ducts over each guidewire. The stents were then released one by one in order of the right posterior sectoral duct, then the left hepatic duct, and then the right anterior sectoral duct. Lastly, three MSs were deployed in the SBS configuration (Fig. 2 and Video S1). No stent occlusion and no adverse events were observed during the follow-up period.

Details are in the caption following the image
(A) Three delivery systems were simultaneously inserted into the left hepatic duct, right anterior sectoral duct, and right posterior sectoral duct across the stricture. (B) The posterior stent was released and deployed. (C) The stent of the left hepatic duct was released and deployed. (D) Lastly, the anterior stent was released, and the three stents were deployed in the side-by-side configuration

Simultaneous triple SBS deployment avoids the risk of the second or third MS deployment failing because the three MSs are inserted simultaneously. This method can be a good option for high-grade MHBO requiring triple stenting, but the technique is only indicated for patients with large CBDs due to overexpansion.

Authors declare no conflicts of interest for this article.

    The full text of this article hosted at iucr.org is unavailable due to technical difficulties.